113 related articles for article (PubMed ID: 23883326)
21. Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study.
Ljungberg B; Gudmundsson E; Christensen S; Lundstam S;
Scand J Urol; 2014 Oct; 48(5):445-52. PubMed ID: 24666103
[TBL] [Abstract][Full Text] [Related]
22. Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.
Thiel DD; Davidiuk AJ; Broderick GA; Arnold M; Diehl N; Tavlarides A; Custer K; Parker AS
BMC Urol; 2015 Jul; 15():58. PubMed ID: 26126615
[TBL] [Abstract][Full Text] [Related]
23. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
[TBL] [Abstract][Full Text] [Related]
24. Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population-based cohort.
Kardos SV; Gross CP; Shah ND; Schulam PG; Trinh QD; Smaldone MC; Sun M; Weight CJ; Sammon J; Han LC; Kim SP
BJU Int; 2014 Oct; 114(4):549-54. PubMed ID: 24571281
[TBL] [Abstract][Full Text] [Related]
25. Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study.
Osthus AA; Aarstad AK; Olofsson J; Aarstad HJ
Oral Oncol; 2011 Oct; 47(10):974-9. PubMed ID: 21856209
[TBL] [Abstract][Full Text] [Related]
26. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.
Zubac DP; Bostad L; Gestblom C; Kihl B; Seidal T; Wentzel-Larsen T; Bakke AM
Scand J Urol Nephrol; 2007; 41(3):191-7. PubMed ID: 17469026
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival after radical surgery for renal cell carcinoma with tumour thrombus extension into the right atrium.
Dominik J; Moravek P; Zacek P; Vojacek J; Brtko M; Podhola M; Pacovsky J; Harrer J
BJU Int; 2013 Mar; 111(3 Pt B):E59-64. PubMed ID: 22984824
[TBL] [Abstract][Full Text] [Related]
28. Operative mortality after nephrectomy for renal cell carcinoma.
Thoroddsen A; Gudbjartsson T; Jonsson E; Gislason T; Einarsson GV
Scand J Urol Nephrol; 2003; 37(6):507-11. PubMed ID: 14675926
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life during treatment for renal cell carcinoma: results from a phase II study of axitinib.
Trask PC; Bushmakin AG; Cappelleri JC; Bycott P; Liau K; Kim S
Acta Oncol; 2008; 47(5):843-51. PubMed ID: 18568482
[TBL] [Abstract][Full Text] [Related]
30. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up.
Somani BK; Nabi G; Thorpe P; N'Dow J; Swami S; McClinton S;
Eur Urol; 2007 May; 51(5):1289-95; discussion 1296-7. PubMed ID: 17081679
[TBL] [Abstract][Full Text] [Related]
31. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
32. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
33. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
[TBL] [Abstract][Full Text] [Related]
34. Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD).
Yap SA; Finelli A; Urbach DR; Tomlinson GA; Alibhai SM
BJU Int; 2015 Jun; 115(6):897-906. PubMed ID: 25065448
[TBL] [Abstract][Full Text] [Related]
35. Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.
Bentzen AG; Balteskard L; Wanderås EH; Frykholm G; Wilsgaard T; Dahl O; Guren MG
Acta Oncol; 2013 May; 52(4):736-44. PubMed ID: 23438358
[TBL] [Abstract][Full Text] [Related]
36. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
37. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
[TBL] [Abstract][Full Text] [Related]
38. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
[TBL] [Abstract][Full Text] [Related]
39. Retroperitoneoscopic versus open surgical radical nephrectomy for large renal cell carcinoma in clinical stage cT2 or cT3a: quality of life, pain and reconvalescence.
Dillenburg W; Poulakis V; Skriapas K; de Vries R; Ferakis N; Witzsch U; Melekos M; Becht E
Eur Urol; 2006 Feb; 49(2):314-22; discussion 322-3. PubMed ID: 16377073
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
